Louisiana State University

LSU Digital Commons
Faculty Publications

Department of Physics & Astronomy

6-2021

Coronavirus Disease (COVID-19): The Value of Chest Radiography
for Patients Greater Than Age 50 Years at an Earlier Timepoint of
Symptoms Compared With Younger Patients
Mae Igi
Louisiana State Univ, Dept Diagnost Radiol, Hlth Sci Ctr, 1542 Tulane Ave,Room 343, New Orleans, LA
70112 USA

Molly Lieux
Louisiana State Univ, Sch Med, Hlth Sci Ctr, New Orleans, LA 70112 USA

Joe Park
Louisiana State Univ, Dept Diagnost Radiol, Hlth Sci Ctr, 1542 Tulane Ave,Room 343, New Orleans, LA
70112 USA

Catherine Batte
Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA

Bradley Spieler
Louisiana State Univ, Dept Diagnost Radiol, Hlth Sci Ctr, 1542 Tulane Ave,Room 343, New Orleans, LA
70112 USA, bspie1@lsuhsc.edu
Follow this and additional works at: https://digitalcommons.lsu.edu/physics_astronomy_pubs
Part of the Medicine and Health Sciences Commons

Recommended Citation
Igi, M., Lieux, M., Park, J., Batte, C., & Spieler, B. (2021). Coronavirus Disease (COVID-19): The Value of
Chest Radiography for Patients Greater Than Age 50 Years at an Earlier Timepoint of Symptoms
Compared With Younger Patients. OCHSNER JOURNAL, 21 (2), 126-132. https://doi.org/10.31486/
toj.20.0102

This Article is brought to you for free and open access by the Department of Physics & Astronomy at LSU Digital
Commons. It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital
Commons. For more information, please contact ir@lsu.edu.

ORIGINAL RESEARCH
Ochsner Journal 21:126–132, 2021
©2021 by the author(s); Creative Commons Attribution License (CC BY)
DOI: 10.31486/toj.20.0102

Coronavirus Disease (COVID-19): The Value of Chest
Radiography for Patients Greater Than Age 50 Years at an
Earlier Timepoint of Symptoms Compared With Younger
Patients
Mae Igi, MD,1 Molly Lieux, BS,2 Joe Park, MD,1 Catherine Batte, MS,3 Bradley Spieler, MD1
of Diagnostic Radiology, Louisiana State University Health Sciences Center, New Orleans, LA 2 Louisiana State University
Health Sciences Center, School of Medicine, New Orleans, LA 3 Department of Physics and Astronomy, Louisiana State University, Baton
Rouge, LA

1 Department

Background: A relative paucity of data exists regarding chest radiography (CXR) in diagnosis of coronavirus disease (COVID-19)
compared to computed tomography. We address the use of a strict pattern of CXR findings for COVID-19 diagnosis, specifically
during early onset of symptoms with respect to patient age.
Methods: We performed a retrospective study of patients under investigation for COVID-19 who presented to the emergency
department during the COVID-19 outbreak of 2020 and had CXR within 1 week of symptoms. Only reverse transcription polymerase
chain reaction (RT-PCR)–positive patients were included. Two board-certified radiologists, blinded to RT-PCR results, assessed 60
CXRs in consensus and assigned 1 of 3 patterns: characteristic, atypical, or negative. Atypical patterns were subdivided into more
suspicious or less suspicious for COVID-19.
Results: Sixty patients were included: 30 patients aged 52 to 88 years and 30 patients aged 19 to 48 years. Ninety-three percent of
the older group demonstrated an abnormal CXR and were more likely to have characteristic and atypical–more suspicious findings
in the first week after symptom onset than the younger group. The relationship between age and CXR findings was statistically significant (χ2 [2, n=60]=15.70; P=0.00039). The relationship between negative and characteristic COVID-19 CXR findings between
the 2 age cohorts was statistically significant with Fisher exact test resulting in a P value of 0.001.
Conclusion: COVID-19 positive patients >50 years show earlier, characteristic patterns of statistically significant CXR changes than
younger patients, suggesting that CXR is useful in the early diagnosis of infection. CXR can be useful in early diagnosis of COVID-19
in patients older than 50 years.
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INTRODUCTION
The coronavirus disease (COVID-19) pandemic of 2020,
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, initially referred to as 2019-nCoV),
has resulted in challenges to essentially all sectors
of global society1 and particularly to the health care
sector.2 The radiology community responded with a
plethora of publications during the relatively short interval of rapid case increases at the beginning of 2020.
Experts across the globe, including the Radiological
Society of North America (RSNA) and the American
College of Radiology,3,4 provided recommendations on
the utility of imaging in diagnosis and management of
COVID-19.
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Most of these recommendations, however, focus on computed tomography (CT) manifestations and not on chest
radiographs (CXRs), with the prevailing theme that CT should
be used sparingly, with a predilection for patients in the
inpatient setting and not as a screening tool.3-5 Further,
much attention was given to the temporal progression of
disease as seen on CT,6-14 specifically the increase in multiplicity and density of airspace opacities, ultimately coalescing into diffuse pulmonary opacification and directly correlating with worsening clinical symptoms.7 Disease progression
from a CXR perspective was addressed relatively less.15-18
Some authors underscore their observations with respect
to patient age, as incidence and severity of clinical outcomes appear to be greater in older individuals infected with
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SARS-CoV-2.19,20 In fact, 2020 publications from Li et al and
Chen et al suggest that the majority of patients they studied
with COVID-19 were older than 50 years and that disease
progression appears to become more rapid with advances
in age.7,21
This greater focus on CT is not surprising given the lower
sensitivity of CXR vs CT for pulmonary disease in general.
However, some centers have used CXR as an adjunct to clinical diagnosis in the early stages of COVID-19, given challenges such as prolonged turnaround time and test variability
for reverse transcription polymerase chain reaction (RT-PCR)
tests and infection issues related to CT scanning.22-25 Wong
et al reported the sensitivity of CXR in detecting COVID-19
to be 69% compared to 91% for RT-PCR,16 but in the Wong
et al study, radiologic evaluation was not geared toward
the typical patterns of reported imaging manifestations of
COVID-19 described in recent (2020) literature17,18 and in
consensus statements from the RSNA.3 Instead, the study
focused on the assessment of pulmonary edema and used
a radiographic assessment of lung edema score.26
In this article, we address the utility of using a strict pattern of findings on CXR for the diagnosis of COVID-19 during
early onset of symptoms in patients older than and younger
than 50 years of age.

METHODS
Our institutional review board approved this retrospective study with waiver of Health Insurance Portability and
Accountability Act authorization in accordance with federal regulations at 45 CFR §164.512(i)(2)(ii). Using the keyword “COVID,” we queried the picture archiving and communication system for patient CXRs performed from January 1, 2020 to April 8, 2020. We then searched the medical record numbers associated with the CXRs in the electronic medical record system at University Medical Center
in New Orleans, Louisiana, for patients who had undergone
COVID-19 RT-PCR assay. Only patients who tested positive by RT-PCR during the same admission were included
in the study. Patients with CXRs performed after 7 days of
symptom onset were excluded so that we could narrow our
assessment of CXR findings to the earliest stages of disease. Symptoms reported by patients at the time of presentation included fever, chills, night sweats, cough, shortness of breath, malaise, loss of appetite, and gastrointestinal
complaints.
The query returned 275 CXRs, and 197 patients were confirmed to be RT-PCR positive. From the 197 patients who

were RT-PCR–positive, 30 CXRs from patients >50 years
and 30 CXRs from patients ࣘ50 years were chosen. All CXRs
were confirmed to have been obtained within 7 days from
onset of symptoms. Sex, age, and date of symptom onset
were collected for the cohort.

Image Acquisition and Analysis
All CXRs were acquired as digital radiographs following
usual institutional protocols using a Philips DigitalDiagnost
system (Koninklijke Philips N.V.). The CXRs were acquired
in anteroposterior projection with patients in upright (22/60,
37%), semi-upright (29/60, 48%), or supine (9/60, 15%)
position, depending on the patients’ dispositions at the time
of image acquisition.

Data Interpretation
Two board-certified radiologists (with more than 5 and 10
years of experience interpreting CXRs following completion
of residency) were blinded to RT-PCR results and clinical history and retrospectively reviewed 60 CXRs in 60 patients
obtained on average within 3 days of symptom onset. The
two reviewers independently assigned one of the following
patterns to each CXR: characteristic, atypical, or negative
(Table 1). Discrepancies in the independent interpretations
were resolved in a consensus session.
The characteristic COVID-19 pattern was defined in accordance with the most commonly reported chest imaging findings of COVID-19 in recent (2019 and 2020) literature, including the presence of bilateral patchy or confluent, bandlike ground glass opacity or consolidation in a peripheral
and mid-to-lower lung zone distribution (Figures 1, 2, and
3).16,27-29 If the CXR showed some but not all these abnormalities, it was assigned to the atypical category. CXRs in the
atypical category were subdivided into categories based on
imaging findings being more suspicious than not for COVID19 or less suspicious for COVID-19. The atypical–more suspicious CXRs had a characteristic pattern seen only in one
lung (Figures 4 and 5). The atypical–less suspicious CXRs
were defined as abnormal but not necessarily showing a typical finding for COVID-19 pneumonia (Figures 6 and 7). A
normal-appearing CXR was categorized as negative.

Statistical Analysis
Statistical analysis was performed using Excel 2018
(Microsoft Corporation). CXR characterizations—negative,
atypical–more suspicious, atypical–less suspicious, and
characteristic—were compared to patient age with a thresh-

Table 1. Chest Radiograph Imaging Classifications16,27-29
Classification

Description

Characteristic COVID-19 appearance

Presence of commonly reported chest imaging findings associated with COVID-19:
bilateral patchy or confluent band-like ground glass opacity or consolidation in a
peripheral and mid-to-lower lung zone distribution

Atypical–more suspicious than not for
COVID-19

Presence of some but not all of the characteristic findings

Atypical–less suspicious for COVID-19

Findings suggestive of a diagnosis other than COVID-19 infection (eg, pulmonary
edema, atelectasis, interstitial changes)

Negative

No abnormal findings
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Figure 1. Portable upright anteroposterior radiograph of
a 65-year-old female shows characteristic bilateral confluent, bandlike (arrows) consolidative opacity in a peripheral,
mid-to-lower lung zone distribution admixed with patchy
airspace opacity.

Figure 3. Portable semi-upright anteroposterior radiograph
of a 66-year-old female shows characteristic bilateral confluent, bandlike (arrows) consolidative opacity in a peripheral,
mid-to-lower lung zone distribution admixed with patchy
airspace opacity, greatest at the left lung base.

old of 50 years using a chi-square test of independence and
Fisher exact test. Significance level was defined as P<0.05.
Interreader agreement was assessed using Cohen kappa
(κ) coefficient. The 2 readers had substantial agreement on
the evaluation of CXRs for COVID-19 (κ=0.743), agreeing on
50 of the 60 (83%) CXRs.30

of ages in the >50 years group was 52 to 88 years (mean, 65
years). The range in the younger group was 19 to 48 years
(mean, 37 years). All 60 patients had a positive COVID-19
RT-PCR assay. Both the older and younger cohorts received
CXRs an average of 3 days after the reported onset of symptoms, with a range of 0 to 5 days in the older group and a
range of 1 to 7 days in the younger group.

RESULTS

Imaging Findings

Of the 60 patients included in the study, 30 (10 males,
20 females) were in the >50 years group and 30 (14 males,
16 females) were in the ࣘ50 years group (Table 2). The range

Table 2 shows the imaging findings by classification and
by group. Overall, 73% (44/60) of the patients included in

Figure 2. Portable upright anteroposterior radiograph of a
72-year-old female shows characteristic bilateral confluent,
bandlike (arrows) consolidative opacity in periphery of the
right mid- and left-lower lung zones.
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Figure 4. Portable upright anteroposterior radiograph of a
30-year-old female shows unilateral confluent, bandlike (arrows) consolidative opacity in the periphery of the right mid
and lower lung zones. This pattern was considered atypical,
but more suspicious for coronavirus disease 2019.
Ochsner Journal
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Table 2. Imaging Results by Age Group and by Sex by Age Group
Chest Radiograph Findingsa
Characteristic

Atypical–More

Atypical–Less

Negative

COVID-19 Appearance

Suspicious

Suspicious

>50 (n=30)

2 (3)

11 (18)

13 (22)

4 (7)

ࣘ50 (n=30)

14 (23)

4 (7)

5 (8)

7 (12)

1 (2)

3 (5)

5 (8)

1 (2)

Variable
Age, years

Sex by age group, years
Male >50 (n=10)
Female >50 (n=20)

1 (2)

8 (13)

8 (13)

3 (5)

Male ࣘ50 (n=14)

8 (13)

3 (5)

0 (0)

3 (5)

Female ࣘ50 (n=16)

6 (10)

1 (2)

5 (8)

4 (7)

Note: All percentages are calculated based on the total number of patients included in the study (n=60).
a
Classifications of chest radiograph findings are defined in Table 1.

this study had an abnormal CXR (Table 3). In the >50 years
group, 93% (28/30) had an abnormal CXR that was classified either as characteristic (classic COVID-19 findings) or as
atypical. Seven percent (2/30) of patients in the >50 years
group had a negative CXR within the first week of presentation from symptom onset. In the same period from symptom
onset, 53% (16/30) of patients in the younger group had an
abnormal CXR, and the other 47% (14/30) had a normal CXR
(Table 3 and Figure 8).
The relationship between age and CXR findings was
statistically significant according to chi-square test ([2,
n=60]=15.70; P=0.00039). In addition, a Fisher exact test
comparing negative and characteristic COVID-19 CXR find-

Figure 5. Portable semi-upright anteroposterior radiograph
of a 56-year-old male shows unilateral thin bandlike (arrows)
consolidative opacity in the periphery of the right mid and
lower lung zones admixed with patchy airspace opacity. This
pattern was considered atypical, but more suspicious for
coronavirus disease 2019.
Volume 21, Number 2, Summer 2021

ings to patient age determined that the relationship was statistically significant (P=0.001). Patients >50 years were more
likely to have characteristic and abnormal suspicious CXR
findings during the first week after symptom onset.

DISCUSSION
Our finding of 73% CXR abnormalities within the first week
of symptom onset in the combined cohort closely approximates other reported measures of sensitivity, such as Wong
et al at 69%16 and Hosseiny et al in which 75% of patients
had a similar distribution of findings in early imaging.31 When
patient age is considered, we demonstrated a 93% sensitivity in patients >50 years and 53% in patients ࣘ50 years in
the first 7 days after symptom onset.
Older age has been associated with poorer outcomes in
COVID-19.31,32 In the United States, 80% of deaths have

Figure 6. Portable supine anteroposterior radiograph of an
80-year-old male shows unilateral discoid (arrow) opacity
along the left hemidiaphragm, typical of subsegmental atelectasis. This pattern was considered atypical and less suspicious for coronavirus disease 2019.
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Figure 8. Chest radiograph findings for patients in the 2 age
cohorts.

Figure 7. Portable upright anteroposterior radiograph of
a 68-year-old female shows prominence of the right hilar
shadow (arrow) and otherwise clear lungs. This pattern was
considered atypical and less suspicious for COVID-19.
occurred in patients ࣙ65 years, and patients ࣙ85 years have
an overwhelming percentage of severe outcomes, mirroring
the reported initial experience in China.33
Many associated factors have been addressed in the literature, such as angiotensin-converting enzyme 2 (ACE2)
receptor, identified as a target of SARS-CoV-2.34 One suggestion is that different levels of ACE2 in younger and older
individuals, in particular with respect to decreasing levels
within the aging tissues of the lungs and heart, may have
an effect on the severity of COVID-19–related disease.35 Liu
et al reported high levels of angiotensin in correlation with
increased viral load of SARS-CoV-2.36 In addition, noncommunicable illnesses associated with advancing age, such as
hypertension and heart disease, in combination with their
associated therapies are generally thought to hinder immune
response.37 Other age-related links in infectious disease
have also been noted. For example, Rivers et al reported
that the major risk factors for progression of disease in Middle East respiratory syndrome (MERS-CoV) were underlying
comorbidities, such as cardiac disease and diabetes, and
age, and the reported mean age in patients considered most
severely ill was 57 years.38

Table 3. Overall Imaging Results by Age Group
Chest Radiograph Findingsa
Age Group, years

Normal

Abnormal

>50 (n=30)

2 (7)

28 (93)

ࣘ50 (n=30)

14 (47)

16 (53)

Note: Percentages are calculated by row (n=30).
a
All negative radiographs are classified as normal. The abnormal category includes radiographs classified as characteristic, atypical–more
suspicious, and atypical–less suspicious.
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While a new strain of coronaviridae, SARS-CoV-2, has
been identified as the causative pathogen for the COVID19 pandemic, the outbreak of severe pulmonary disease
caused by a strain of this viral family is not unique. MERSCoV and severe acute respiratory syndrome (SARS-CoV) are
the most salient examples. While no outbreaks of SARSCoV have been reported since April 2004, MERS-CoV cases
have been reported as recently as January 2020.39 Both syndromes have imaging features similar to COVID-19,31 which
is important because symptoms associated with COVID-19
have been reported to be milder than those of MERS-CoV,40
allowing for a potentially greater role for imaging in disease
management, particularly in patients at greater risk for disease severity—the older population.
Much is still unknown regarding patients’ future immunity
to COVID-19 after convalescence. The immune system of
older adults undergoes numerous age-related changes, collectively termed immune senescence, that leave older adults
particularly vulnerable to new, emerging infectious diseases,
such as possible reinfection by COVID-19 or infection with
new variants.33
Limitations of our study include the small sample size at
a single institution, lack of follow-up serial CXR or subsequent CT scans that may have been performed, and inclusion of only RT-PCR–positive patients. Selection bias was
also present because all patients were chosen from a subset
that received imaging, potentially because of a more severe
course of illness. Additionally, descriptions of the temporal
progression of disease used in this study have been defined
almost entirely by recent publications on CT findings. With
the rapid increase in number of abnormalities and distribution peaking 6 to 11 days after onset, identifying how
patients with a worsening course presented on early CXR
will be important.14 Despite global vaccination efforts, there
is still concern that the disease could produce enough severe
illness to further strain some health care infrastructures,
especially with new variants circulating in the community.
As a result, health care providers need to be able to predict
which patients will have a more complex course of illness.41
Early CXR correlation with patient course of illness and
outcomes could be critical in anticipating what resources
will be needed in the coordination of care for COVID-19
patients.
Ochsner Journal

Igi, M

CONCLUSION
We conclude that CXR in patients >50 years within 1
week of symptom onset in COVID-19 offers potential benefits, whereas a negative CXR in patients ࣘ50 years has limited sensitivity. Imaging obtained early in presentation of disease, especially for patients older than 50 years, may help to
inform an estimate of resource use.
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